Online citations, reference lists, and bibliographies.

Diabetes Mellitus As A Predictor Of Cancer Mortality In A Large Cohort Of US Adults.

Steven Scott Coughlin, Eugenia E. Calle, Lauren R Teras, Jennifer M. Petrelli, Michael J. Thun
Published 2004 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Several studies have suggested that diabetes mellitus may alter the risk of developing a variety of cancers, and the associations are biologically plausible. To learn more about the relation between diabetes and cancer mortality, the authors examined associations with selected cancers in a large, prospective US cohort of 467,922 men and 588,321 women who had no reported history of cancer at enrollment in 1982. After 16 years of mortality follow-up, diabetes was significantly associated with fatal colon cancer in men (multivariate relative risk (RR) = 1.20, 95% confidence interval (CI): 1.06, 1.37) and women (RR = 1.24, 95% CI: 1.07, 1.43) and with pancreatic cancer in men (RR = 1.48, 95% CI: 1.27, 1.73) and women (RR = 1.44, 95% CI: 1.21, 1.72). For men, diabetes was significantly associated with liver cancer (RR = 2.19, 95% CI: 1.76, 2.72) and bladder cancer (RR = 1.43, 95% CI: 1.14, 1.80). In addition, diabetes was significantly associated with breast cancer in women (RR = 1.27, 95% CI: 1.11, 1.45). These associations were not explained by high body mass. Our findings suggest that diabetes is an independent predictor of mortality from cancer of the colon, pancreas, female breast, and, in men, of the liver and bladder.
This paper references
10.1093/oxfordjournals.aje.a116664
Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants.
Eugenia E. Calle (1993)
Prevalence of hypertension and diabetes in breast cancer: a case-control study in 179 patients and age-matched, non-hospitalized controls.
Hans Olov Adami (1978)
10.1023/A:1026580131793
Predictors of pancreatic cancer mortality among a large cohort of United States adults
Steven Scott Coughlin (2000)
10.1002/(SICI)1097-0215(19960611)66:6<723::AID-IJC2>3.0.CO;2-1
International renal-cell-cancer study. VI. the role of medical and family history.
Brigitte Schlehofer (1996)
10.1016/0277-5379(90)90151-i
Breast cancer risk and history of selected medical conditions linked with female hormones.
Silvia Franceschi (1990)
10.1023/A:1008819701485
Diabetes mellitus and pancreaticcancer mortality in a prospectivecohort of United States adults
Eugenia E. Calle (1998)
10.1093/ije/22.6.1000
The influence of medical conditions associated with hormones on the risk of breast cancer.
Miriam Moseson (1993)
10.1016/S0002-9378(00)70486-8
Risk factors among young women with endometrial cancer: a Danish case-control study.
M Parslov (2000)
10.1007/BF00051670
Cancer risk in patients with diabetes mellitus
Hans-Olov Adami (1991)
10.1126/science.279.5350.563
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
June M. Chan (1998)
10.2105/ajph.88.5.765
Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus.
Seppo Koskinen (1998)
10.1097/00001648-199801000-00021
Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer.
Thomas A. Sellers (1998)
10.1007/BF00052674
Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States)
Amanda I. Adler (2004)
10.1006/pmed.1996.9979
Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
Marc T. Goodman (1997)
Am J Epidemiol
(2004)
International classification of diseases . Manual of the international statistical classification of diseases, injuries, and causes of death
Health World (1977)
10.1093/jnci/91.7.620
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
J Ma (1999)
Diabetes and breast cancer risk.
S Kopp (1990)
10.1093/oxfordjournals.aje.a009534
Colorectal cancer: another complication of diabetes mellitus?
J. C. Ogilvie Will (1998)
10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.
Adda Grimberg (2000)
10.1159/000053161
IGFs and Human Cancer: Implications Regarding the Risk of Growth Hormone Therapy
Melanie L Shim (1999)
10.2105/AJPH.71.3.242
Accuracy of cancer death certificates and its effect on cancer mortality statistics.
Constance Percy (1981)
10.1097/00001648-199809000-00016
Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast.
Kari Bohlke (1998)
Regression models and life tables (with discussion
David Roxbee Cox (1972)
10.1001/jama.283.19.2552
Abnormal glucose metabolism and pancreatic cancer mortality.
Susan M Gapstur (2000)
10.1038/sj.bjc.6690607
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer
Debra T. Silverman (1999)
10.1093/jnci/59.4.1055
Epidemiology of endometrial cancer.
J Mark Elwood (1977)
Diabetes Mellitus and Colorectal Cancer Risk 1
Carlo la Vecchia (2005)
10.1038/bjc.1994.427
A case-control study of diabetes mellitus and cancer risk.
Carlo la Vecchia (1994)
10.1093/jnci/89.4.314
Medical history risk factors for non-Hodgkin's lymphoma in older women.
James R. Cerhan (1997)
10.1093/oxfordjournals.aje.a116576
Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men.
Geoffrey D. Smith (1992)
10.2105/ajph.69.7.680
Studies on the reliability of vital and health records: I. Comparison of cause of death and hospital record diagnoses.
A Gittelsohn (1979)
10.1001/jama.1995.03520440059037
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.
James E. Everhart (1995)
10.1002/(SICI)1097-0215(19971009)73:2<204::AID-IJC7>3.0.CO;2-#
Diabetes mellitus and the risk of primary liver cancer
Carlo la Vecchia (1997)
10.1002/(SICI)1097-0215(19990702)82:1<38::AID-IJC8>3.0.CO;2-Q
Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry.
Paul Terry (1999)
10.1093/jnci/89.18.1360
Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.
Louise Wideroff (1997)
10.1023/A:1008822917449
Diabetes mellitus and risk of prostate cancer (United States)
Edward L. Giovannucci (1998)
10.1093/jnci/83.24.1820
Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California.
Mimi C. Yu (1991)
10.1038/bjc.1997.289
Selected medical conditions and risk of breast cancer.
Renato Talamini (1997)
10.1093/jnci/87.12.930
Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden.
W. H. Chow (1995)
10.1007/BF00053150
Risk factors for renal cell carcinoma: results of a population-based case-control study
Nancy Kreiger (2004)
10.1093/oxfordjournals.qjmed.a068053
Diabetes mellitus and primary hepatocellular carcinoma.
David H. Lawson (1986)
10.1002/(SICI)1097-0215(19990517)81:4<539::AID-IJC6>3.0.CO;2-Q
Diabetes and endometrial cancer: an Italian case-control study.
Fabio Parazzini (1999)
10.1016/0021-9681(82)90025-X
Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus.
Mark W. Ragozzino (1982)
10.1023/A:1005831013718
Insulin and related factors in premenopausal breast cancer risk
M Elisabeth Del Giudice (1998)
10.1093/jnci/44.3.673
Cancer mortality among diabetics.
Irving I. Kessler (1970)
10.1097/00001648-199905000-00021
Is diabetes mellitus associated with prostate cancer incidence and survival?
J. C. Ogilvie Will (1999)
Insulin-like growth factor-I and binding pro- tein-3 and risk of cancer
E Giovannucci (1999)
10.1016/0021-9681(85)90139-0
Diabetes mellitus and cancer risk: a multisite case-control study.
B A O'Mara (1985)
10.1093/jnci/88.20.1472
Excess risk of primary liver cancer in patients with diabetes mellitus.
Hans Olov Adami (1996)
10.1007/s00423-004-0469-8
Diabetes mellitus: a risk factor for pancreatic cancer?
Mehmet Yalnız (2004)
10.1093/oxfordjournals.aje.a009630
Diabetes, body size, and risk of endometrial cancer.
Suzanne M Shoff (1998)
10.1093/ije/23.5.923
Risk factors for renal cell carcinoma in Denmark: role of medication and medical history.
Anders Mellemgaard (1994)
10.1159/000053160
Insulin-Like Growth Factor-I and Binding Protein-3 and Risk of Cancer
Edward L. Giovannucci (1999)
Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer.
Loïc Le Marchand (1997)
10.1038/bjc.1997.520
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
Christos S. Mantzoros (1997)
10.1054/ghir.2000.0171
Does the GH-IGF axis play a role in cancer pathogenesis?
Pinchas Cohen (2000)
10.1002/ijc.2910520402
Insulin resistance and breast-cancer risk.
Peter F. Bruning (1992)
Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology 1999;10:313–18
JC Will (1999)
Medical history and primary liver cancer.
Carlo la Vecchia (1990)
10.1016/0090-8258(74)90003-1
Risk factors for endometrial cancer.
Brian Macmahon (1974)
10.1016/0277-5379(91)90223-Z
History of selected diseases and the risk of colorectal cancer.
Carlo la Vecchia (1991)
10.1016/S0002-9378(11)91709-8
Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study.
Louise A Brinton (1992)
10.1023/A:1008946825313
Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)
Elisabete Weiderpass (2004)
10.3892/ijo.8.3.439
Case-control study on colon cancer regarding previous diseases and drug intake.
Lennart Hardell (1996)
10.1093/ije/dym193
Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.
Gabriel A. Kune (1988)
10.1001/jama.286.8.921
Physical activity, obesity, height, and the risk of pancreatic cancer.
Dominique S Michaud (2001)
10.1093/jnci/90.12.911
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.
Alicja Wolk (1998)



This paper is referenced by
10.1371/journal.pone.0084776
Diabetes Mellitus Is Associated with Hepatocellular Carcinoma: A Retrospective Case-Control Study in Hepatitis Endemic Area
Ze Zheng (2013)
10.3332/ecancer.2015.596
Risk factors and biomarkers of life-threatening cancers
Philippe Autier (2015)
10.3810/pgm.2014.10.2825
Diabetes Mellitus as a Novel Risk Factor for Gastrointestinal Malignancies
Dana J Herrigel (2014)
10.1111/iju.12644
Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review.
Francesco Cantiello (2015)
Diabetes mellitus and risk of bladder cancer : an updated meta-analysis of 36 observational studies
Zhaowei Zhu (2012)
10.1038/s41416-018-0314-4
Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts
Yanan Ma (2018)
Meta-Analysis Type 2 Diabetes Mellitus and Risk of Non-Hodgkin Lymphoma : A Systematic Review and Meta-Analysis
Chun Chao (2008)
10.1016/j.currproblcancer.2019.05.007
The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy.
Serdar Arici (2019)
Population-based estimation of mortalityand occurrence of cancer in patientswith and without diabetes in Pune
Rajiv Kumar (2013)
10.1371/journal.pone.0176068
The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies
Bo Zhu (2017)
Insulin Receptor Signaling is Necessary for the Maintenance of Epithelial Phenotype in MCF10A Cells
Vanessa Palma (2013)
10.1097/MD.0000000000008588
Diabetes mellitus and the risk of bladder cancer
Yongping Xu (2017)
10.3748/wjg.v22.i43.9571
Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation
Qing Zhang (2016)
10.1007/978-94-007-5971-8_13
Cancer Predisposition in Diabetic Patients: Risk Assessment and Targeted Preventive Measures
Melanie Cebioglu (2013)
10.1200/JCO.2011.38.0303
Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Ahmed N Dehal (2012)
10.1186/bcr3089
Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes
Rosalyn D. Ferguson (2011)
10.1089/dia.2011.0019
Overall mortality in diabetes mellitus: where do we stand today?
George E Dailey (2011)
Facteurs alimentaires, composantes du syndrome métabolique et risques de cancer du sein et de diabète de type II dans la cohorte E3N
Guy Fagherazzi (2011)
Mechanisms of Action of Metformin as an Anti-cancer Agent
Vijayalekshmi Ramachandran Nair Vasanthakum (2014)
10.18632/aging.102245
A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer
Audrius Dulskas (2019)
Impacts of chronic disease on breast cervical and colorectal cancer screening in rural Oregon
Betty Y J Liu (2012)
10.1681/ASN.2005050552
Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease.
Vandana Menon (2005)
10.1016/j.joms.2020.01.018
Influence of Hyperglycemia on Treatment Outcomes of Oral Cavity Squamous Cell Carcinoma.
Kuang-Hsu Lien (2020)
10.2741/4017
Hyperglycemia as a mechanism of pancreatic cancer metastasis.
Wei Li (2012)
10.1016/j.metabol.2015.07.005
Inhibition of tumor energy pathways for targeted esophagus cancer therapy.
Abbas Shafaee (2015)
Gender Differences in Elders’ Participation in the National Cancer Screening Program: Evidence from the Korean National Health and Nutrition Examination Survey 2010–12
Yang-Hyun Kim (2015)
10.1016/S0140-6736(14)60886-2
The global implications of diabetes and cancer
Yuankai Shi (2014)
BODY COMPOSITION ANALYSIS IN THE ASSESSMENT OF CANCER CACHEXIA TREATMENT OUTCOMES
Alireza Aslani (2008)
10.1177/107327480701400103
Interaction between comorbidity and cancer.
Martine Extermann (2007)
10.1016/j.diabres.2017.11.002
An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis.
Mayer B Davidson (2018)
10.1016/j.ygyno.2014.07.095
Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies.
Caiyun Liao (2014)
10.7314/APJCP.2013.14.10.5687
PKC?-dependent activation of the ubiquitin proteasome system is responsible for high glucose-induced human breast cancer MCF-7 cell proliferation, migration and invasion.
Shan An Zhu (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar